Literature DB >> 10495137

Bone mineralization at the callotasis site after completion of lengthening.

N Maffulli1, J C Cheng, A Sher, B K Ng, E Ng.   

Abstract

We studied the course of bone mineralization of regenerate bone after callotasis lengthening. Twenty-three patients (eight boys) (mean age at operation 11.5 years, range 4-17 years; leg length discrepancy [LLD] at surgery ranging from 4 to 13 cm) underwent dual-energy X-ray absorptiometry (DEXA) scanning weekly during the distraction phase, at 2 week intervals until removal of the fixator, and at the time of their out-patient visits thereafter, for a mean of 794 +/- 420 days after removal of the apparatus. At removal of the fixator, the bone mineral content (BMC) of the regenerate was nearly 70% of the normal contralateral limb. With time, this value gradually increased, and tended to reach normal values, with no significant difference between femur and tibia. With time, the BMC of the regenerate tends to return to the value of the normal contralateral limb. Probably, once the limb length discrepancy has been equalized, the mechanical stimuli imparted through weight-bearing to the lengthened limb are of the same magnitude bilaterally. In this instance, then, the newly formed bone, responding to these physical stimuli, would normalize its mineral content, confirming that bone remodeling continues well after lengthening is terminated. Mineralization of the regenerate after completion of the lengthening process reaches values significantly greater than at removal of the fixator, with an increase of >50% of the prelengthening values, regardless of the underlying pathology. The final value of this increased BMC is not significantly different than in the normal contralateral unoperated limb. At least part of the increase in bone mineralization following callotasis lengthening is due to the normal process of growth and development.

Entities:  

Mesh:

Year:  1999        PMID: 10495137     DOI: 10.1016/s8756-3282(99)00168-4

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  7 in total

1.  Callus patterns in femur lengthening using a monolateral external fixator.

Authors:  Dileep Isaac; Harry Fernandez; Hae-Ryong Song; Tae-Young Kim; Ashok Kumar Shyam; Seok-Hyun Lee; Jong-Chan Lee
Journal:  Skeletal Radiol       Date:  2007-11-16       Impact factor: 2.199

2.  Objective guidelines for removing an external fixator after tibial lengthening using pixel value ratio: a pilot study.

Authors:  Li Zhao; Qing Fan; K P Venkatesh; Man S Park; Hae Ryong Song
Journal:  Clin Orthop Relat Res       Date:  2009-08-06       Impact factor: 4.176

3.  Quantitative assessment of mineralization in distraction osteogenesis.

Authors:  Sunit Hazra; Hae-Ryong Song; Sandeep Biswal; Suk-Ha Lee; Seok Hyun Lee; Ki-Mo Jang; Hitesh N Modi
Journal:  Skeletal Radiol       Date:  2008-04-24       Impact factor: 2.199

4.  Distraction osteogenesis using a longitudinal corticotomy.

Authors:  Ma'ad F Al-Saati; Robert A Magnussen; Sebastien Lustig; Rodolphe Testa; Gazal Al-Saati; Faisal Al-Saati
Journal:  Int Orthop       Date:  2011-10-28       Impact factor: 3.075

5.  Bone lengthening osteogenesis, a combination of intramembranous and endochondral ossification: an experimental study in sheep.

Authors:  Francisco Forriol; Luca Denaro; Umile Giuseppe Longo; Hirofumi Taira; Nicola Maffulli; Vincenzo Denaro
Journal:  Strategies Trauma Limb Reconstr       Date:  2010-03-10

6.  Callus features of regenerate fracture cases in femoral lengthening in achondroplasia.

Authors:  Kamlesh N Devmurari; Hae Ryong Song; Hitesh N Modi; K P Venkatesh; Kim Seung Ju; Sang Heon Song
Journal:  Skeletal Radiol       Date:  2009-07-02       Impact factor: 2.199

7.  Evaluating the Utility of the Pixel Value Ratio in the Determination of Time to Full Weight-bearing in Patients Undergoing Intramedullary Limb Lengthening.

Authors:  Anirejuoritse Bafor; Molly E Duncan; Christopher A Iobst
Journal:  Strategies Trauma Limb Reconstr       Date:  2020 May-Aug
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.